<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000538.v1.p1" parentStudy="phs000538.v1.p1" createDate="2012-08-28" modDate="2012-08-28">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Gail Jarvik, MD, PhD</td><td>University of Washington, Seattle, WA, USA</td></tr>
		<tr><td>Funding Source</td><td>HI30086</td><td>National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Source</td><td>265508</td><td>Northwest Institute of Genetic Medicine, Washington State Life Sciences Discovery Funds, Seattle, WA, USA</td></tr>
		<tr><td>Sequencing Center</td><td>Northwest Genomics Center (NWGC; Director: Deborah Nickerson)</td><td>University of Washington, Seattle, WA, USA</td></tr>
		<tr><td>Funding Source for Sequencing</td><td>HG005608</td><td>National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Next Generation Mendelian Genetics: Familial Combined Hyperlipidemia</StudyNameEntrez>
	<StudyNameReportPage>Next Generation Mendelian Genetics: Familial Combined Hyperlipidemia</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Family</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>The NHGRI Next Generation Mendelian Genetics project uses exome resequencing to identify variants in unsolved Mendelian diseases.</p> <p>The research study procedures included the collection of a fasting blood sample, 2 medical history/life style questionnaires and a measurement of subjects&#39; waist circumference that were completed many years ago. Blood samples were analyzed for metabolic markers including cholesterol, HDL, triglycerides and APOE. Genetic tests targeted known and novel genes and polymorphisms associated with carotid artery disease. </p>]]>
	</Description>
	<StudyInEx><![CDATA[
<ol><p><li>Elevated metabolic lipoprotein values</li></p> <p><li>Family member with elevated metabolic lipoprotein values</li></p> <p><li>Personal or family history of cardiovascular disease</li></p> </ol>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Hyperlipidemia, Familial Combined"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Gail Jarvik, MD, PhD</AttName>
			<Institution>University of Washington, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>HI30086</AttName>
			<Institution>National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>265508</AttName>
			<Institution>Northwest Institute of Genetic Medicine, Washington State Life Sciences Discovery Funds, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Sequencing Center">
			<AttName>Northwest Genomics Center (NWGC; Director: Deborah Nickerson)</AttName>
			<Institution>University of Washington, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Funding Source for Sequencing">
			<AttName>HG005608</AttName>
			<Institution>National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyHistory><![CDATA[
<p>Subjects in this study are members of a few defined, multi-generational families with multiple members diagnosed with elevated lipoprotein levels. Probands presented at a University department of Metabolism, Endocrinology and Nutrition with very high values of blood fat and family histories of cardiovascular disease. Pedigrees determined multiple family members with similar histories. Approximately 250 probands and family members that were enrolled into the IRB approved study have been followed for more than 25 years. Males and females are roughly equal in numbers, and the vast majority is Caucasian and enrolled in the research as adults.</p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="2" shortName="HD" longName="Heart Disease"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NHGRI</DacName>
      <DacFullName>National Human Genome Research Institute</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000538.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000538.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000538.v1.p1" FileName="Familial_Hyperlipidemia_DUC_04142011.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="2">
        <ConsentName>Heart Disease</ConsentName>
        <ConsentAbbrev>HD</ConsentAbbrev>
        <UseLimitation>Data Access is limited to researchers working to identify the cause of heart disease</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
